MicroRNAs in resolution of acute inflammation: Identification of novel resolvin D1-miRNA circuits

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 544-560

  Recchiuti, Antonio ^a   Krishnamoorthy, Sriram ^a   Fredman, Gabrielle ^a   Chiang, Nan ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

5 lipoxygenase; Cytokines; GPCR; Lipid mediators; Resolution indices; Transcription factors

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE; MICRORNA; RESOLVIN D1 PROTEIN; SMAD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXUDATE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MEDIATOR; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ACUTE DISEASE; ANIMALS; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION REGULATION; INFLAMMATION; MICE; MICRORNAS; PERITONITIS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; ZYMOSAN;

MURINAE;

EID: 79551625082     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-169599     Document Type: Article

References (50)

1. Ryan, G. B., and Majno, G. (1977) Acute inflammation. A review. Am. J. Pathol. 86, 183-276
2. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416
3. Serhan, C. N. (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137
4. Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., and Serhan, C. N. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355
5. Schwab, J. M., Chiang, N., Arita, M., and Serhan, C. N. (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874
6. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., and Levy, B. D. (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873-879
7. Navarro-Xavier, R. A., Newson, J., Silveira, V. L., Farrow, S. N., Gilroy, D. W., and Bystrom, J. (2010) A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184, 1516-1525
8. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332
9. Nathan, C., and Ding, A. (2010) Nonresolving inflammation. Cell 140, 871-882
10. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008) Cancer-related inflammation. Nature 454, 436-444
11. Randolph, G. J. (2009) The fate of monocytes in atherosclerosis. J. Thromb. Haemost. 7(Suppl. 1), 28-30
12. Serhan, C. N. (2009) Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 7(Suppl. 1), 44-48
13. Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S., and Serhan, C. N. (2004) Aspirin triggers antiinflammatory 15-epilipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. U. S. A. 101, 15178-15183
14. Morris, T., Stables, M., Hobbs, A., de Souza, P., Colville-Nash, P., Warner, T., Newson, J., Bellingan, G., and Gilroy, D. W. (2009) Effects of low-dose aspirin on acute inflammatory responses in humans. J. Immunol. 183, 2089-2096
15. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R. L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037
16. Sun, Y. P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., and Serhan, C. N. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-9334
17. Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., and Serhan, C. N. (2008) Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181, 8677-8687
18. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C. H., Yang, R., Petasis, N. A., and Serhan, C. N. (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U. S. A. 107, 1660-1665
19. Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., and Chan, L. (2008) Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595-3606
20. Rossi, A. G., and Sawatzky, D. A., eds (2008) The Resolution of Inflammation, Birkhäuser Verlag AG, Basel
21. Tabas, I. (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36-46
22. Majno, G. (1982) Inflammation and infection: historic high-lights. In Current Topics in Inflammation and Infection (Majno, G., Cotran, R. S., and Kaufman, N., eds) pp. 1-17, Williams & Wilkins, Baltimore
23. Majno, G., Cotran, R. S., and Kaufman, N., eds (1982) Current Topics in Inflammation and Infection, Vol. 23, Williams & Wilkins, Baltimore
24. Shimizu, T. (2009) Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49, 123-150
25. Iorio, M. V., and Croce, C. M. (2009) MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 27, 5848-5856
26. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854
27. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
28. Sheedy, F. J., and O'Neill, L. A. (2008) Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann. Rheum. Dis. 67(Suppl. 3), iii50 -iii55
29. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722
30. Ambros, V., Bartel, B., Bartel, D. P., Burge, C. B., Carrington, J. C., Chen, X., Dreyfuss, G., Eddy, S. R., Griffiths-Jones, S., Marshall, M., Matzke, M., Ruvkun, G., and Tuschl, T. (2003) A uniform system for microRNA annotation. RNA 9, 277-279
31. -ΔΔCT method. Methods 25, 402-408
32. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., and Li, T. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 37, D105-D110
33. Naga Prasad, S. V., Duan, Z. H., Gupta, M. K., Surampudi, V. S., Volinia, S., Calin, G. A., Liu, C. G., Kotwal, A., Moravec, C. S., Starling, R. C., Perez, D. M., Sen, S., Wu, Q., Plow, E. F., Croce, C. M., and Karnik, S. (2009) Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J. Biol. Chem. 284, 27487-27499
34. Serhan, C. N., Lu, Y., Hong, S., and Yang, R. (2007) Mediator lipidomics: search algorithms for eicosanoids, resolvins and protectins. Methods Enzymol. 432, 275-317
35. Winyard, P. G., and Willoughby, D. A., eds (2003) Inflammation Protocols, Humana, Totowa, NJ, USA
36. Clish, C. B., O'Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., and Serhan, C. N. (1999) Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. U. S. A. 96, 8247-8252
37. Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., and O'Neill, L. A. (2009) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141-147
38. Inui, M., Martello, G., and Piccolo, S. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell. Biol. 11, 252-263
39. Papagiannakopoulos, T., Shapiro, A., and Kosik, K. S. (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 68, 8164-8172
40. Callis, T. E., Pandya, K., Seok, H. Y., Tang, R. H., Tatsuguchi, M., Huang, Z. P., Chen, J. F., Deng, Z., Gunn, B., Shumate, J., Willis, M. S., Selzman, C. H., and Wang, D. Z. (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772-2786
41. Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., and Barres, B. A. (2010) Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65, 597-611
42. Yang, H. S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., and Colburn, N. H. (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 23, 26-37
43. Loh, P. G., Yang, H. S., Walsh, M. A., Wang, Q., Wang, X., Cheng, Z., Liu, D., and Song, H. (2009) Structural basis for translational inhibition by the tumour suppressor Pdcd4. EMBO J. 28, 274-285
44. Samuelsson, B., Dahlen, S. E., Lindgren, J. A., Rouzer, C. A., and Serhan, C. N. (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237, 1171-1176
45. Samuelsson, B. (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568-575
46. Radmark, O., Werz, O., Steinhilber, D., and Samuelsson, B. (2007) 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 32, 332-341
47. Dincbas-Renqvist, V., Pepin, G., Rakonjac, M., Plante, I., Ouellet, D. L., Hermansson, A., Goulet, I., Doucet, J., Samuelsson, B., Radmark, O., and Provost, P. (2009) Human Dicer C-terminus functions as a 5-lipoxygenase binding domain. Biochim. Biophys. Acta 1789, 99-108
48. Connor, K. M., SanGiovanni, J. P., Lofqvist, C., Aderman, C. M., Chen, J., Higuchi, A., Hong, S., Pravda, E. A., Majchrzak, S., Carper, D., Hellstrom, A., Kang, J. X., Chew, E. Y., Salem, N., Jr., Serhan, C. N., and Smith, L. E. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13, 868-873
49. Bannenberg, G., Moussignac, R. L., Gronert, K., Devchand, P. R., Schmidt, B. A., Guilford, W. J., Bauman, J. G., Subramanyam, B., Perez, H. D., Parkinson, J. F., and Serhan, C. N. (2004) Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br. J. Pharmacol. 143, 43-52
50. Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., and Spite, M. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 15-23